New Token Deal Lets Dental Tech Raise Money on Solana
A Historic Milestone in Private Markets
In a groundbreaking collaboration, First Block, Onpharma, and Crito Capital have launched what appears to be the first U.S. operating company to issue tokenized shares on Solana’s blockchain. This move is poised to redefine how private enterprises raise capital globally, leveraging the speed, scalability, and efficiency of Solana’s low-cost network.
How It Works: Tokenized Shares with Regulatory Compliance
The offering—structured as a Regulation S offshore deal—enables Onpharma to reach international investors while remaining fully compliant with U.S. securities regulations. By tokenizing shares on Solana, the transaction eliminates traditional intermediaries, reducing costs and accelerating settlement times—a critical advantage for private markets.
Onpharma: Disrupting Dental Anesthesia with a Game-Changing Device
The Problem: A Decades-Old Pain Point
Dental injections have long been a source of discomfort for patients. Onpharma’s Onset EZ Pen changes that by speeding up local anesthesia, making procedures faster and less painful. With millions of uses annually and a growing adoption rate among dentists, the device is positioned for explosive growth.
A Market Ripe for Innovation
The global market for pain management in dentistry is projected to exceed $2.65 billion by 2030. Onpharma, now at a critical inflection point—having secured production, supply chains, and regulatory approvals—aims to dominate this space. The newly raised capital will fuel scaling sales teams, AI-driven marketing, and global expansion, positioning the company as a leader in the $2.65B+ opportunity.
The Power Behind the Deal: Three Firms, One Vision
1. First Block: The Digital Securities Platform
First Block provides the backbone of this tokenized offering, managing compliance checks, investor onboarding, and on-chain settlement. By digitizing the entire process, the platform reduces friction, cuts costs, and ensures seamless transactions—all without the need for traditional brokers or custodians.
2. Crito Capital: Banking & Regulatory Expertise
Crito Capital plays a pivotal role in structuring the deal for institutional investors while ensuring full regulatory adherence. Their deep understanding of banking and securities law helps mitigate risk and build trust in this novel fundraising model.
3. Onpharma: The Real-World Asset Backing the Tokens
Onpharma isn’t just another tech startup—it’s a healthcare innovator with a proven product in high demand. The tokenized shares represent real ownership in a company with a clear path to profitability, making this a compelling case study for blockchain-based capital raising.
Could This Be the Future of Private Markets?
If this venture succeeds, it could unlock a new era of tokenized securities, where businesses—from healthcare to tech—raise capital faster, cheaper, and with greater accessibility. The implications are vast: ✔ Faster settlements (minutes, not days) ✔ Lower costs (no middlemen, lower fees) ✔ Global investor access (24/7, borderless markets)
For Onpharma, this isn’t just about funding—it’s about pioneering a new model for how private companies grow. And for the rest of the world? It might just be the first domino in a much larger transformation.
Stay tuned—this could be the beginning of a revolution.
